Current Oncology

Established in 1994, Current Oncology is a peer-reviewed, Canadian based and Internationally distributed journal. Published bi-monthly plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Current Oncology is published by Multimed Inc.

Current Oncology is indexed/covered in PubMed, EMBASE (Excerpta Medica Database), Scopus, Journal Selector, CrossRef, Index Copernicus, DOAJ (Directory of Open Access Journals), Google Scholar, EMCare, Research Databases, Science Citation Index Expanded (SciSearch), and Journal Citation Reports/Science Edition. Following publication in Current Oncology, the full text of each article is available immediately and archived in PubMed Central (PMC), the U.S. National Library of Medicine's digital archive of biomedical and life sciences journal literature. It is also available in the databases of 100 libraries worldwide, and is a participant of the HINARI program.

The information provided on the Current Oncology website is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.



Journal Announcement: Current Oncology, Vol 22, Suppl 1 - Now Published!

Updated Guidelines, Consensus and Evidence-Based Reports in Breast Cancer

Multimed Inc. is pleased to announce that Current Oncology has published a supplement dedicated to breast cancer, edited by Dr. Maureen Trudeau from the Sunnybrook Health Sciences Centre in Toronto, Ontario.

The supplement is comprised of the most recent adjuvant breast cancer guidelines completed for the Program in Evidence Based Care of Cancer Care Oncology (CCO).  Readers will be able to find up to date and evidence based guidelines and consensus documents all in one place.

The supplement also includes evidence based reviews or consensus recommendations on locally advanced breast cancer for both local/regional management and systemic treatment. A Canadian group of content experts have been working on appropriate algorithms for neoadjuvant treatment over the last few years and had just completed a set of recommendations which have been included in the supplement; and another CCO guideline on local/regional management of locally advanced disease was just completed as well.

A Canadian flair was added to summaries based on International guidelines already published by Canadian experts with special interest in the treatment of HER2+ and HER2- disease.

Lastly, a review of pregnancy related breast cancer -breast cancer during pregnancy or pregnancy after breast cancer -was included as a topic of special interest for the management of the many young women with breast cancer.

We would like to thank all of the contributing oncologists for their work on this special supplement. We would also like to send a special thank you to Dr. Maureen Trudeau for her hard work and dedication in creating this important tool for oncologists.

Click here to read the supplement.

Posted: 2015-03-23

Meeting/Conference: Join us for the Best of ASCO – Toronto, Montreal, Vancouver!’s Best of ASCO® Conference is a program licensed by the American Society of Clinical Oncology. Held June 11th, 2015 in Montreal, June 12th in Toronto and July 10th in Vancouver.  The focus of this event will be to provide medical oncologists and other healthcare practitioners in Canada with a summary of the most significant treatment advances presented at the ASCO 2015 Annual Meeting, with presentations focused on several key disease sites. 

Meeting Objectives:

  1. To summarize the most significant treatment advances presented at ASCO 2015;
  2. To review the current standard of care for key malignancies; and
  3. To discuss the current controversies in the management of specific cancers.

Target Audience:

Medical oncologists, pharmacists, nurses, and other oncology healthcare professionals.

Other Information:

This meeting has been approved by the American Society of Clinical Oncology. Best of ASCO® and any related logos are trademarks of the American Society of Clinical Oncology®.  All continuing medical education credits are transferable between the USA and Canada.

Visit our website for more details!

Posted: 2015-03-19

Meeting/Conference: Join Canadian Oncology Pharmacists at CAPhO Conference 2015 in St. John’s, May 21 – 24, 2015




Register now to participate in this year's CAPhO Conference 2015 (CAPhO 2015), a leading edge annual educational event produced by the Canadian Association of Pharmacy in Oncology (CAPhO) that defines the practice of oncology pharmacy in Canada. CAPhO 2015 will be held May 21- 24, 2015 at the Delta St. John’s Hotel and Conference Centre.

The three-day program is an ensemble of satellite symposia, plenary sessions, breakout sessions and networking events. The theme of CAPhO 2015 is Change, Challenge and Opportunity.

Change: Personalized medicine with complex targeted therapies, innovative delivery models, and patient engagement have changed the way cancer is treated. 

Challenge: Significant advances in the treatment of cancer come at a turbulent time, as the population is aging, the incidence of cancer is on the rise and the costs of providing treatment are continually escalating. 

Opportunity: With change and challenge comes opportunity, particularly for oncology pharmacists.

If you are an oncology pharmacist, technician, pharmacy assistant and other health care professional interested in the practice of oncology pharmacy in Canada, register today to attend CAPhO 2015 and become a member of CAPhO.  Also sign up to receive the e-newsletter so that you stay informed.

Posted: 2015-02-13 More...
More Announcements...

Vol 22 (2015): Updated Guidelines, Consensus and Evidence-Based Reports in Breast Cancer

Cover Page


During the past 6 years, stage IV breast cancer has brought loss and sorrow from the depths of darkness. I have received such an outpouring of love and compassion from friends and family giving me inspiration and encouragement. Their continued support for my every need is tremendous, making an almost unbearable situation turn into an experience of healing. It empowers me to face every day with an attitude of gratitude and to continue reaching for the stars. I wanted to create a permanent expression of my gratefulness and pay tribute to everyone, including my doctors, nurses, therapists, and counselors who continue to provide treatment and professional guidance. I persevere with the knowledge that with all this support, my spirit will be eternally uplifted.

The acrylic painting on the cover of this issue is titled “Uplifted” and is by a person diagnosed with cancer from the 2014 Oncology On Canvas Art Competition and Exhibition.

Oncology On CanvasSM is an art competition and exhibition that honours the journeys people face when confronted with a cancer diagnosis. This biennial competition invites individuals diagnosed with any type of cancer—as well as their families, friends, caregivers and healthcare providers—to express, through art and narrative, the life-affirming changes that give their cancer journeys meaning.

Oncology On Canvas was started in 2004 by Lilly Oncology to help address a great, unmet need in cancer care—a need that goes beyond medicine—to help those affected by cancer cope with the emotional toll of the disease. Since 2004, the National Coalition for Cancer Survivorship (NCCS) has been the co-presenter of the Lilly Oncology On Canvas Art Competition and Exhibition for US and Puerto Rico residents.

Lilly Oncology on Canvas Canada launched in 2014. Visit to learn more about the competition. Lilly Oncology on Canvas Canada is presented in partnership with the Canadian Association for Psychosocial Oncology and the Canadian Cancer Survivor Network.

Current Oncology is committed to the Canadian oncology community as well as oncology communities around the world. We are pleased to help raise awareness of this great program created by Lilly Oncology. Current Oncology will be selecting a new artwork for each cover from the Oncology On Canvas competition.

Copyright © 2015 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)